These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27686044)

  • 1. Cholesterol metabolism as a prognostic marker in patients with mildly symptomatic nonischemic dilated cardiomyopathy.
    Sawamura A; Okumura T; Hiraiwa H; Aoki S; Kondo T; Ichii T; Furusawa K; Watanabe N; Kano N; Fukaya K; Morimoto R; Bando YK; Murohara T
    J Cardiol; 2017 Jun; 69(6):888-894. PubMed ID: 27686044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Selvester QRS score as a predictor of cardiac events in nonischemic dilated cardiomyopathy.
    Hiraiwa H; Okumura T; Sawamura A; Sugiura Y; Kondo T; Watanabe N; Aoki S; Ichii T; Kitagawa K; Kano N; Fukaya K; Furusawa K; Morimoto R; Takeshita K; Bando YK; Murohara T
    J Cardiol; 2018 Mar; 71(3):284-290. PubMed ID: 29066100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged QRS duration and severity of mitral regurgitation are unfavorable prognostic markers of heart failure in patients with nonischemic dilated cardiomyopathy.
    Amiya E; Tanabe K; Ikari Y; Nakajima Y; Hara K
    Circ J; 2006 Jan; 70(1):57-62. PubMed ID: 16377925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes of Autologous Stem Cell-Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy.
    Domae K; Miyagawa S; Yoshikawa Y; Fukushima S; Hata H; Saito S; Kainuma S; Kashiyama N; Iseoka H; Ito E; Harada A; Takeda M; Sakata Y; Toda K; Pak K; Yamada T; Sawa Y
    J Am Heart Assoc; 2021 Jul; 10(13):e008649. PubMed ID: 34212772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological variation of β-sitosterol, campesterol, and lathosterol as cholesterol absorption and synthesis biomarkers.
    Wu AH; Ruan W; Todd J; Lynch KL
    Clin Chim Acta; 2014 Mar; 430():43-7. PubMed ID: 24394292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Plasma Branched-Chain Amino Acid Analysis in Predicting Outcomes of Patients with Nonischemic Dilated Cardiomyopathy.
    Kimura Y; Okumura T; Kazama S; Shibata N; Oishi H; Arao Y; Kuwayama T; Kato H; Yamaguchi S; Hiraiwa H; Kondo T; Morimoto R; Murohara T
    Int Heart J; 2020 Jul; 61(4):739-747. PubMed ID: 32684600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in cholesterol homeostasis are associated with coronary heart disease in patients with aortic stenosis.
    Weingärtner O; Weingärtner N; Scheller B; Lütjohann D; Gräber S; Schäfers HJ; Böhm M; Laufs U
    Coron Artery Dis; 2009 Sep; 20(6):376-82. PubMed ID: 19620855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic assessment of right ventricular function in routine practice: Which parameters are useful to predict one-year outcome in advanced heart failure patients with dilated cardiomyopathy?
    Kawata T; Daimon M; Kimura K; Nakao T; Lee SL; Hirokawa M; Kato TS; Watanabe M; Yatomi Y; Komuro I
    J Cardiol; 2017 Oct; 70(4):316-322. PubMed ID: 28341544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
    Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.
    Puntmann VO; Carr-White G; Jabbour A; Yu CY; Gebker R; Kelle S; Hinojar R; Doltra A; Varma N; Child N; Rogers T; Suna G; Arroyo Ucar E; Goodman B; Khan S; Dabir D; Herrmann E; Zeiher AM; Nagel E;
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):40-50. PubMed ID: 26762873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy.
    Komamura K; Sasaki T; Hanatani A; Kim J; Hashimura K; Ishida Y; Ohkaru Y; Asayama K; Tanaka T; Ogai A; Nakatani T; Kitamura S; Kangawa K; Miyatake K; Kitakaze M
    Heart; 2006 May; 92(5):615-8. PubMed ID: 16387818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid-stimulating hormone within the normal range and risk of major adverse cardiovascular events in nonischemic dilated cardiomyopathy patients with severe left ventricular dysfunction.
    Li X; Yao Y; Chen Z; Fan S; Hua W; Zhang S; Fan X
    Clin Cardiol; 2019 Jan; 42(1):120-128. PubMed ID: 30447088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of tissue Doppler right ventricular systolic and diastolic function indexes combined with plasma B-type natriuretic Peptide in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Bistola V; Parissis JT; Paraskevaidis I; Panou F; Nikolaou M; Ikonomidis I; Flessas N; Filippatos G; Iliodromitis E; Kremastinos DT
    Am J Cardiol; 2010 Jan; 105(2):249-54. PubMed ID: 20102927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal Circadian Blood Pressure Profile as a Prognostic Marker in Patients with Nonischemic Dilated Cardiomyopathy.
    Sawamura A; Okumura T; Takeshita K; Watanabe N; Kano N; Mori H; Fukaya K; Morimoto R; Hirashiki A; Bando YK; Murohara T
    Cardiology; 2017; 136(1):1-9. PubMed ID: 27537378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic utility of anemia and pro-B-type natriuretic peptide in patients with nonischemic dilated cardiomyopathy and normal renal function.
    Tigen K; Karaahmet T; Cevik C; Gurel E; Mutlu B; Basaran Y
    Am J Med Sci; 2009 Feb; 337(2):109-15. PubMed ID: 19214026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of a Simple Echocardiographic Parameter, the Right Ventricular Systolic to Diastolic Duration Ratio, in Patients with Advanced Heart Failure with Non-Ischemic Dilated Cardiomyopathy.
    Xu B; Kawata T; Daimon M; Kimura K; Nakao T; Lee SC; Hirokawa M; Yoshinaga A; Watanabe M; Yatomi Y; Komuro I
    Int Heart J; 2018 Sep; 59(5):968-975. PubMed ID: 30022771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Campesterol Is Positively Associated with Carotid Plaques in Asymptomatic Subjects.
    Nunes VS; de Campos EVS; Baracat J; França V; Gomes ÉIL; Coelho RP; Nakandakare ER; Zago VHS; de Faria EC; Quintão ECR
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral fat positively correlates with cholesterol synthesis in dyslipidaemic patients.
    Lupattelli G; Pirro M; Mannarino MR; Siepi D; Roscini AR; Schillaci G; Mannarino E
    Eur J Clin Invest; 2012 Feb; 42(2):164-70. PubMed ID: 21793822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.